Braveheart Bio, Inc. · NASDAQ:BRVE
Lubner David Charles bought 55,555 Braveheart Bio, Inc. shares (Form 4)
Traded Aug 7, 2026 · Filed Aug 7, 2026
On Aug 7, 2026, Lubner David Charles (Director) bought 55,555 Braveheart Bio, Inc. shares at US$18.00 for US$1000K, leaving 55,555 shares. Filed Aug 7, 2026 (Form 4).
- Bought
- 55,555 shares
- Price
- US$18.00
- Value
- US$1000K
- Holding after
- 55,555 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 7, 2026 | Common Stock | Buy | 55,555 | US$18.00 | 55,555 | Direct |
Source
Related
- Braveheart Bio, Inc.
- Lubner David Charles
- Braveheart Bio, Inc. shareholders
- Schedule 13D/A · Orbimed Advisors LLC · Sep 10, 2026
- Schedule 13D · Orbimed Advisors LLC · Aug 18, 2026
- Schedule 13G · Frazier Life Sciences Public Fund, L.P. · Aug 14, 2026
- Schedule 13D · AH Bio Fund IV, L.P. · Aug 14, 2026
- Form 4 · Andreessen Marc L · Aug 11, 2026